EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for RGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
March 31, 2026 -5.59
December 31, 2025 -3.754
September 30, 2025 -3.490
June 30, 2025 -3.464
March 31, 2025 -3.135
December 31, 2024 -4.638
September 30, 2024 -5.034
June 30, 2024 -5.269
March 31, 2024 -5.877
December 31, 2023 -6.027
September 30, 2023 -5.982
June 30, 2023 -6.319
March 31, 2023 -6.246
December 31, 2022 -6.498
September 30, 2022 1.556
June 30, 2022 1.931
March 31, 2022 2.157
December 31, 2021 2.745
September 30, 2021 -5.161
June 30, 2021 -3.565
March 31, 2021 -3.115
December 31, 2020 -2.995
September 30, 2020 -2.476
Date Value
June 30, 2020 -3.642
March 31, 2020 -2.775
December 31, 2019 -2.582
September 30, 2019 -1.755
June 30, 2019 -1.380
March 31, 2019 -1.041
December 31, 2018 2.886
September 30, 2018 2.265
June 30, 2018 2.16
March 31, 2018 1.39
December 31, 2017 -2.47
September 30, 2017 -2.701
June 30, 2017 -2.716
March 31, 2017 -2.794
December 31, 2016 -2.383
September 30, 2016 -1.842
June 30, 2016 -2.681
March 31, 2016 -2.479
December 31, 2015 -2.165
September 30, 2015 -1.957
June 30, 2015 -0.4325
March 31, 2015 -0.0869
March 31, 2014 0.0081

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Ocugen, Inc. -0.2318
Capricor Therapeutics, Inc. -2.313
Krystal Biotech, Inc. 7.482
Biogen, Inc. 9.318
AbbVie, Inc. 2.027